On this page you will find clinical guidance and treatment pathways that have been approved by GMMMG or its Subgroups.

The table headings below are active links; click a heading to sort in ascending or descending order.

Document Title Issue Date Review Date Status
GMMMG Tobacco Dependency Treatment Guideline 20220227 Feb 2022 20250127 Jan 2025
Antimicrobial Guidelines 20211027 Oct 2021 20220127 Jan 2022 This guideline is reviewed quarterly; comments will be accepted continuously
Dental Antimicrobial Guidelines 20200227 Feb 2020 20230227 Feb 2023
Asthma Management Plan 20220427 Apr 2022
Asthma Management Plan - Inhaler Guide Under review
COPD Management Plan 20211127 Nov 2021 20230927 Sep 2023
COPD Management Plan - inhaler guide 20211227 Dec 2021 20230927 Sep 2023
Benzodiazepine and Z-drug prescribing: Resource Pack 20210527 May 2021 20240527 May 2024
Gabapentinoids - Prescribing for pain resource pack 20210727 Jul 2021 20230727 Jul 2023
Gabapentinoids - Prescribing for pain resource pack - editable version 20210727 Jul 2021 20230727 Jul 2023
Chronic urticaria in primary care for adults and children 20170927 Sep 2017 20190927 Sep 2019
Cow's milk protein allergy: prescribing infant formula for in primary care 20200427 Apr 2020 20230427 Apr 2023
Dermatology pathways: Management of acne in primary care 20190427 Apr 2019 20220127 Jan 2022 Under review
Dermatology pathways: Management of actinic keratoses in primary care 20190427 Apr 2019 20220127 Jan 2022
Dermatology pathways: Management of eczema in primary care 20190427 Apr 2019 20220127 Jan 2022
Dermatology pathways: Emollient ladder 20190427 Apr 2019 20220127 Jan 2022
Dermatology pathways: Management of psoriasis in primary care 20190427 Apr 2019 20220127 Jan 2022
Dermatology pathways: Steroid ladder 20190427 Apr 2019 20220127 Jan 2022
Dermatology pathways: Management of warts in primary care 20190427 Apr 2019 20220127 Jan 2022
DOAC prescriber decision support 20200227 Feb 2020 20221127 Nov 2022
Gender Dysphoria - Supporting information for GPs 20170427 Apr 2017 20200427 Apr 2020
The Royal College of Psychiatrists' Oct 2013: Good Practice Guidelines for the Assessment and Treatment of Adults with Gender Dysphoria 20131027 Oct 2013 20181027 Oct 2018
GP guide - lnfluenza outbreak in an adult care home 20190127 Jan 2019 20220127 Jan 2022
High Cost Drug Pathway for Ankylosing Spondylitis and Psoriatic Arthritis 20180127 Jan 2018 20180927 Sep 2018
High Cost Drug Pathways for Inflammatory Bowel Disease in Adults 20190627 Jun 2019 20191227 Dec 2019
High Cost Drugs Pathway for Psoriasis 20200127 Jan 2020 20221127 Nov 2022
High Cost Drugs Pathway for Psoriasis – outcomes & monitoring framework 20200127 Jan 2020 20210127 Jan 2021
High cost drugs pathway for Rheumatoid Arthritis 20171227 Dec 2017 20190727 Jul 2019
Inappropriate Polypharmacy Review and Treatment Optimisation: Resource Pack 20210927 Sep 2021 20220327 Mar 2022
Insulin Prescribing Aid for Adults with Type 2 Diabetes 20191127 Nov 2019 20221127 Nov 2022
Low strength antipsychotic prescribing in dementia: a resource for GPs 20151127 Nov 2015 20181127 Nov 2018
Neuropathic Pain in Adults - Guideline for Primary Care 20220527 May 2022 20250527 May 2025
Management of overactive bladder in adults 20190827 Aug 2019 20220827 Aug 2022
Macular drugs pathways 20171127 Nov 2017 20191027 Oct 2019
North West Headache Pathway 20150927 Sep 2015
North West Headache Pathway Guideline Notes 20150627 Jun 2015 20170627 Jun 2017
Opioid Prescribing for Chronic Pain: Resource Pack 20180827 Aug 2018 20210927 Sep 2021
Palliative Care Pain and Symptom Control Guidelines for Adults 20191127 Nov 2019 20221127 Nov 2022 Developed in line with GMMMG process by the Greater Manchester and Eastern Cheshire Strategic Clinical Networks. Adopted for use by GMMMG
PCSK9 inhibitors in the treatment of hypercholesterolaemia 20191127 Nov 2019 20211127 Nov 2021
Prescribing guidance in the self-monitoring of blood glucose (SMBG) 20151227 Dec 2015 20181227 Dec 2018
Trans-Anal Irrigation (TAI) Pathway 20171227 Dec 2017 20221227 Dec 2022